Tecogen (TGEN) director adds 5,000 shares in open-market buy
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Tecogen Inc. director Earl Lewis reported an open-market purchase of 5,000 shares of Tecogen common stock at an average price of $2.5192 per share. The filing shows that, following this transaction, Lewis directly or through a trust associated with him holds 1,011,006 Tecogen shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 5,000 shares ($12,596)
Net Buy
1 txn
Insider
Lewis Earl
Role
Director
Bought
5,000 shs ($13K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 5,000 | $2.5192 | $13K |
Holdings After Transaction:
Common Stock — 1,011,006 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Tecogen (TGEN) report for Earl Lewis?
Tecogen director Earl Lewis reported buying 5,000 shares of common stock in an open-market transaction. The purchase was at an average price of $2.5192 per share and increased his directly or trust-associated holdings to 1,011,006 shares.
Was the Tecogen (TGEN) insider transaction a buy or a sell?
The transaction was a buy. The Form 4 shows Earl Lewis executed an open-market purchase of 5,000 Tecogen common shares, coded as a "P" transaction and described as a purchase in an open market or private transaction.
What does the trust reference mean in the Tecogen (TGEN) Form 4 footnote?
A footnote states the shares were "acquired by trust," indicating the 5,000 purchased shares are held through a trust associated with Earl Lewis. The filing still reports these as his direct ownership for Section 16 reporting purposes.